Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1001959

registered interest
date	05/11/2018
answering body	Foreign and Commonwealth Office
answering dept id	16
answering dept short name	Foreign and Commonwealth Office
answering dept sort name	Foreign and Commonwealth Office
hansard heading	Papua: Human Rights
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign and Commonwealth Affairs, whether officials in (a) his Department and (b) the Indonesian Embassy have met the non-governmental organizations (i) Tapol and (ii) Etan to discuss human rights in West Papua.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	188246
answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>Officials in London have not met representatives from Tapol since 2013 and we have no record of meetings with ETAN. Officials in Jakarta last met Tapol in Jakarta in March 2018 and are planning to meet them again in November. During regular visits to Papua, embassy officials meet local government officials, civil society groups, businesses and local communities to discuss issues such as human rights, economic development and sustainable forest management.</p><p>​</p> answering member constituency Cities of London and Westminster answering member printed Mark Field question first answered 12/11/2018 16:25:15 answering member 1405 label Biography information for Mark Field
tabling member	4657 label Biography information for Anneliese Dodds

999490

registered interest
date	01/11/2018
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Insurance Premium Tax
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, what assessment he has made of the effect of changes in the rate of insurance premium tax on the cost of insurance premiums since 2011.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	187137
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>As my Rt Hon friend Mel Stride MP set out on 10 September 2018, it is difficult to isolate the impact of insurance premium tax rate increases from other factors impacting on the price of insurance products.</p><p> </p><p>The Government nonetheless publishes prospective impact assessments for the changes in the rate of Insurance Premium Tax (IPT).</p><p> </p><p>The assessment for the last change (announced at Autumn Statement 2016) can be found here:</p><p> </p><p><a href="https://www.gov.uk/government/publications/insurance-premium-tax-increase-of-standard-rate/insurance-premium-tax-increase-of-standard-rate" target="_blank">https://www.gov.uk/government/publications/insurance-premium-tax-increase-of-standard-rate/insurance-premium-tax-increase-of-standard-rate</a></p> answering member constituency Salisbury answering member printed John Glen question first answered 06/11/2018 15:48:04 answering member 4051 label Biography information for John Glen
tabling member	4657 label Biography information for Anneliese Dodds

999493

registered interest
date	01/11/2018
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Sanitary Products: Taxation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, what assessment he has made of the level of taxation on sanitary items in countries outside the EU.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	187140
answer	answer is ministerial correction date of answer 09/11/2018 answer text <p>The Government has not made an assessment of the level of taxation on sanitary items in countries outside the EU.</p><p> </p><p>We are committed to introducing a zero rate of VAT for these supplies as soon as legally possible.</p><p> </p> answering member constituency Central Devon answering member printed Mel Stride question first answered 09/11/2018 14:51:42 answering member 3935 label Biography information for Mel Stride
tabling member	4657 label Biography information for Anneliese Dodds

999498

registered interest
date	01/11/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Undocumented Migrants: Arrests
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what the Government's policy is on suspected illegal migrants being arrested in public places.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	187141
answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>Guidance on when and how Immigration Enforcement officers may arrest suspected illegal migrants can be found at:<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/537682/Arrest-and-restraint-v1.pdf" target="_blank"> https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/537682/Arrest-and-restraint-v1.pdf</a></p><p>All immigration enforcement visits and operations which may involve arrest, require authorisation. Operations in public places are subject to a higher level of authorisation than other types of enforcement visit or operation and require the completion of a comprehensive risk and intelligence assessment. The nature of immigration enforcement activity means that there may be unplanned encounters as part of a planned operation. In such situations, officers will undertake a dynamic risk assessment and any action will be taken within the parameters of the guidance and the powers available to the officer.</p> answering member constituency Romsey and Southampton North answering member printed Caroline Nokes question first answered 20/11/2018 17:02:42 answering member 4048 label Biography information for Caroline Nokes
tabling member	4657 label Biography information for Anneliese Dodds

999499

registered interest
date	01/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how NICE (a) classifies and (b) regulates new treatments made up of a combination of active substances.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	187142
answer	answer is ministerial correction date of answer 07/11/2018 answer text <p>The National Institute for Health and Care Excellence does not classify or regulate new treatments. Licensing of new medicines, including combinations of active substances, is undertaken by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicine Agency in consultation with the MHRA. The MHRA is the Government agency responsible for ensuring that medicines and medical devices work and are acceptably safe.</p><p> </p><p>Most combinations of active substances are so-called ‘fixed combinations’ – most commonly a tablet containing two or more different medicines. Fixed combination applications can be classified as:</p><p>- Products containing one or more new active substances;</p><p>- Products containing a combination of previously licenced substances; and</p><p>- Generic copies of the above.</p><p> </p><p>The legal basis for the regulation of combination medicinal products is given in European Union Directive 2001/83/EC as amended, and subsequently implemented into United Kingdom medicines legislation. The specific legal basis and the data requirements for combination medicinal products vary depending on the active substances in the combination, the development undertaken, and the licenced indications of the product.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 07/11/2018 12:34:52 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4657 label Biography information for Anneliese Dodds

999500

registered interest
date	01/11/2018
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Financial Services: EU Law
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, how many provisions in financial and related regulations which require transposition into UK law in the event of the UK leaving the EU without a deal include thresholds measuring the proportion of (a) the entire EU market or (b) a specified number or grouping of member states.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	187143
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>The European Union (Withdrawal) Act 2018 (EUWA) repeals the European Communities Act 1972 on the day the UK leaves the EU and incorporates into UK domestic law the existing body of directly applicable EU law. The purpose of the EUWA is to provide a functioning statute book on the day we leave the EU.</p><p>In some instances, the retained EU law relating to financial services includes provisions that relate to thresholds measuring the proportion of the entire EU market or a specified number or grouping of member states. We are aware of four provisions in the Markets in Financial Instruments Regulations (MiFIR) (Article 5(1)(a) and 1(b), and subparagraphs (3)-(6) and subparagraph (9), Article 9(5), Article 14(5), Article 36(5)), five provisions in the Commission Delegated Regulation amending MiFID 565/2017 (Article 12 to 16) and one provision in the Commission Delegated Regulation 2017/567 (Article 5(1)(a) and (b)).</p> answering member constituency Salisbury answering member printed John Glen question first answered 06/11/2018 17:13:40 answering member 4051 label Biography information for John Glen
tabling member	4657 label Biography information for Anneliese Dodds

999626

registered interest
date	01/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Integrated Care Systems
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of Integrated Care Provider contracts on improving (a) quality of care and (b) value for money.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	187144
answer	answer is ministerial correction date of answer 07/11/2018 answer text <p>NHS England launched a 12 week public consultation on the proposed contracting arrangements for integrated care providers (ICPs) on 3 August 2018 which concluded on 26 October. More information is available at the following link:</p><p> </p><p><a href="https://www.engage.england.nhs.uk/consultation/proposed-contracting-arrangements-for-icps/" target="_blank">https://www.engage.england.nhs.uk/consultation/proposed-contracting-arrangements-for-icps/</a></p><p> </p><p>No ICP contracts have been placed in England. If, subject to the outcome of the consultation, NHS England decides to make the ICP Contract available for commissioners to use, it plans to study the impact of any ICP Contract arrangements.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 07/11/2018 12:28:06 answering member 4095 label Biography information for Steve Barclay
tabling member	4657 label Biography information for Anneliese Dodds

999627

registered interest
date	01/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Integrated Care Systems
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that Integrated Care Provider contracts do not divert resources away from acute services operated by the same provider.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	187145
answer	answer is ministerial correction date of answer 07/11/2018 answer text <p>NHS England launched a 12 week public consultation on the proposed contracting arrangements for integrated care providers (ICPs) on 3 August 2018 which concluded on 26 October. More information is available at the following link:</p><p> </p><p><a href="https://www.engage.england.nhs.uk/consultation/proposed-contracting-arrangements-for-icps/" target="_blank">https://www.engage.england.nhs.uk/consultation/proposed-contracting-arrangements-for-icps/</a></p><p> </p><p>The consultation documents provide more detail about the NHS England’s current proposals for ICPs, including:</p><p>- An overview of integrated budgets; and</p><p>- A summary of the types of organisations that might hold the proposed ICP Contract.</p><p> </p><p>The draft ICP Contract has been designed to enable a more collaborative, integrated model of care to be delivered, focusing on prevention.</p><p> </p><p>The ICP proposals would do nothing to change the level of resources available in local areas, and any decision to award a new contract or change existing contracts would be for local commissioners following full engagement with patients, the public and existing providers.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 07/11/2018 12:19:19 answering member 4095 label Biography information for Steve Barclay
tabling member	4657 label Biography information for Anneliese Dodds

997559

registered interest
date	30/10/2018
answering body	Prime Minister
answering dept id	23
answering dept short name	Prime Minister
answering dept sort name	Prime Minister
hansard heading	Syed Kamall
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Prime Minister, with reference to the reported comments of Syed Kamall MEP, on 24 October 2018, what representations she has made to her counterpart in the European Parliament on this matter.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	185805
answer	answer is ministerial correction date of answer 05/11/2018 answer text <p>Syed Kamall MEP has apologised for his reported comments</p> answering member constituency Maidenhead answering member printed Mrs Theresa May question first answered 05/11/2018 14:58:21 answering member 8 label Biography information for Mrs Theresa May
tabling member	4657 label Biography information for Anneliese Dodds

993599

registered interest
date	23/10/2018
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Multinational Companies: Taxation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, how much revenue was lost to the public purse as a result of the exemption for regulatory capital in section 259N(3)(b) Chapter 8 Part 6A Taxation (International and Other Provisions) Act 2010 in each year since the introduction of that exemption.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	182824
answer	answer is ministerial correction date of answer 26/10/2018 answer text <p>As a matter of corporation tax policy, with the aim of improving financial stability, the UK allows certain deductions for the costs of regulatory capital. The exemption referred to helps to ensure that the Hybrid and Other Mismatch Rules act in a way consistent with this policy. As such, there is no question of any tax revenue being “lost” as a result of the exemption.</p><p>It is not possible to provide details of the tax effect arising from the exemption for regulatory capital in section 259N(3)(b), Chapter 8, Part 6A of the Taxation (International and other Provisions) Act 2010.</p><p>The Hybrid and other mismatches regime came into force on 1 January 2017. The majority of corporation tax returns which will reflect the impact of these rules have not yet been received.</p> answering member constituency Central Devon answering member printed Mel Stride question first answered 26/10/2018 13:46:56 answering member 3935 label Biography information for Mel Stride
tabling member	4657 label Biography information for Anneliese Dodds